The Science Behind the Dream
The world’s richest and most powerful are obsessed with immortality. Holly Baxter digs into whether the Elon Musks and Vladimir Putins of the world can really ‘live to 150’ — and what that might mean for the rest of us. Wednesday 23 September 2026 12:
The pursuit of extreme longevity has become a quiet obsession among global elites. From Silicon Valley tech moguls to political leaders, there is growing interest in anti-aging research, gene editing, and experimental therapies. Billions are being poured into biotech startups promising to slow or reverse aging. This trend reflects not just personal ambition but a desire to maintain power and influence indefinitely.
Who Gets to Live Forever?
Researchers are exploring telomere extension, senolytic drugs, and cellular reprogramming to delay age-related diseases. While some animal studies show promise, human trials remain limited and ethically complex. Critics warn that these technologies could deepen inequality, creating a biological divide between those who can afford extended life and those who cannot. Proponents argue that breakthroughs will eventually benefit everyone, much like vaccines or antibiotics.
Access to life-extending treatments is likely to be uneven from the start. Early adopters will almost certainly be the wealthy and well-connected, raising questions about fairness and social stability. If leaders like Xi Jinping or Donald Trump could remain cognitively and physically vigorous past traditional retirement age, it might reshape succession planning in authoritarian and democratic systems alike. The prospect of indefinite rule, even if unintended, challenges norms of term limits and generational change.
Can anyone really live to 150 today? No current technology allows humans to reach 150 years of life. The oldest verified person lived to 122. Scientific efforts aim to extend healthy lifespan, not achieve immortality.
Frequently Asked Questions
Will anti-aging treatments be available to everyone? Initially, these therapies will likely be expensive and accessible only to the wealthy. Widespread access depends on cost reductions, regulatory approval, and public funding over time.
What are the risks of significantly longer lifespans? Longer lives could strain pension systems, healthcare, and resources. They may also concentrate power in the hands of those who live longer, affecting leadership turnover and societal dynamism.